PMVP
PMVP
NASDAQ · Biotechnology

Pmv Pharmaceuticals Inc

$1.04
+0.02 (+1.96%)
As of Feb 8, 2:17 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 14.44M 13.53M 15.01M
Net Income -947,825 -765,390 -987,033
EPS
Profit Margin -6.6% -5.7% -6.6%
Rev Growth +21.5% +1.8% +6.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 22.71M 20.12M 23.50M
Total Equity 24.32M 21.76M 23.84M
D/E Ratio 0.93 0.92 0.99
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -1,267,375 -1,123,871 -1,333,015
Free Cash Flow -656,212 -624,188 -715,122